An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System

计划入组 25 人 · 首次发布于 2019 年 12 月 13 日

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

计划入组 1,921 人 · 首次发布于 2016 年 3 月 17 日

ADVATE Post Authorization Safety Surveillance

计划入组 108 人 · 首次发布于 2005 年 9 月 22 日

Nirmatrelvir(Paxlovid)

C₂₃H₃₂F₃N₅O₄

Iodide I-123

I

Octenidine

C₃₆H₆₂N₄ · Rx

ABBVIE

United States

PainReform

Israel

Notable Labs

Israel

Pharmacy-Led Prior Authorization Model Dramatically Reduces Cancer Treatment Delays

AMA Debates Physician Compensation for Prior Authorization Work at Interim Meeting

UnitedHealthcare Launches Nationwide 'Gold Card' Program to Streamline Prior Authorization Process